Open AccessMyocardial Infarction Subtypes in Patients With Type 2 Diabetes Mellitus and the Effect of Liraglutide Therapy (from the LEADER Trial)
Author(s) -
S.P. Marso,
M.A. Nauck,
T. Monk Fries,
S. Rasmussen,
M.B. Treppendahl,
J.B. Buse,
LEADER Publication Committee on behalf of the LEADER Trial Investigators
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/13n0-cc93
Subject(s) - liraglutide , medicine , myocardial infarction , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes , cardiology , clinical trial , endocrinology